Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Insights into the Pharmacogenetics of Tacrolimus Pharmacokinetics and Pharmacodynamics
Mercè Brunet, Marçal Pastor‐Anglada
Pharmaceutics (2022) Vol. 14, Iss. 9, pp. 1755-1755
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Pharmacomicrobiomics: Immunosuppressive Drugs and Microbiome Interactions in Transplantation
Moataz E. Mohamed, Abdelrahman Saqr, Christopher Staley, et al.
Transplantation (2024) Vol. 108, Iss. 9, pp. 1895-1910
Closed Access | Times Cited: 7
Tacrolimus‐Related Neurotoxicity of the Pons in Children: Review of the Literature and a Case Report
A.G. Hill, Mohamed Bilal Haradwala, Jean‐Baptiste Le Pichon
Annals of the Child Neurology Society (2025)
Open Access
Implementation of clinical pharmacogenetic testing in medically underserved patients: a narrative review
Brian E. Gawronski, Irina Fofanova, Angel M. Miranda, et al.
Pharmacogenomics (2025), pp. 1-13
Closed Access
Effects of CYP3A5 Genotype on Tacrolimus Pharmacokinetics and Graft-versus-Host Disease Incidence in Allogeneic Hematopoietic Stem Cell Transplantation
Daniel N. Marco, Mònica Molina, Ana-María Guio, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 553-553
Open Access | Times Cited: 4
CYP3A5 and POR gene polymorphisms as predictors of infection and graft rejection in post-liver transplant patients treated with tacrolimus - a cohort study
Graziella D’ Agostino Ribeiro Naldi, A. Minari, Thales Pereira, et al.
The Pharmacogenomics Journal (2025) Vol. 25, Iss. 2
Open Access
Whole-Exome Sequencing Followed by dPCR-Based Personalized Genetic Approach in Solid Organ Transplantation: A Study Protocol and Preliminary Results
Mirgul Bayanova, Aidos Bolatov, Dias Malik, et al.
Methods and Protocols (2025) Vol. 8, Iss. 2, pp. 27-27
Open Access
Optimizing tacrolimus dosage in post-renal transplantation using DoseOptimal framework: profiling CYP3A5 genetic variants for interpretability
Chintal Upendra Raval, Ashwin Makwana, Samir Patel, et al.
International Journal of Clinical Pharmacy (2025)
Closed Access
Safety analysis of co-administering tacrolimus and omeprazole in renal transplant recipients – A review
Miłosz Miedziaszczyk, Ilona Idasiak‐Piechocka
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115149-115149
Open Access | Times Cited: 10
Should we abandon therapeutic drug monitoring of tacrolimus in whole blood and move to intracellular concentration measurements?
Suwasin Udomkarnjananun, Thanee Eiamsitrakoon, Brenda C. M. de Winter, et al.
British Journal of Clinical Pharmacology (2023)
Open Access | Times Cited: 7
The macrocycle inhibitor landscape of SLC‐transporter
Nejra Granulo, Sergey Sosnin, Daniela Digles, et al.
Molecular Informatics (2024) Vol. 43, Iss. 5
Open Access | Times Cited: 2
Impact of intra-patient variability of tacrolimus on allograft function and CD4 + /CD8 + ratio in kidney transplant recipients: a retrospective single-center study
Xuebin Wang, Zhengyue Liu, Jingxia Chen, et al.
International Journal of Clinical Pharmacy (2024) Vol. 46, Iss. 4, pp. 918-925
Closed Access | Times Cited: 2
A Drug Safety Briefing (II) in Transplantation from Real-World Individual Pharmacotherapy Management to Prevent Patient and Graft from Polypharmacy Risks at the Very Earliest Stage
Ursula Wolf
Pharmaceuticals (2024) Vol. 17, Iss. 3, pp. 294-294
Open Access | Times Cited: 1
Tacrolimus Variability and Clinical Outcomes in the Early Post-lung Transplantation Period: Oral Versus Continuous Intravenous Administration
Julia E. M. van Dommelen, H. Grootjans, Esther V. Uijtendaal, et al.
Clinical Pharmacokinetics (2024) Vol. 63, Iss. 5, pp. 683-693
Open Access | Times Cited: 1
Bacterial Influence on Pharmacokinetics of Tacrolimus and Sulfasalazine through Regulation of Host Metabolism
David A. Cooper, Abhinav Bhushan
Advanced Therapeutics (2024) Vol. 7, Iss. 8
Closed Access | Times Cited: 1
A Drug Safety Concept (I) to Avoid Polypharmacy Risks in Transplantation by Individual Pharmacotherapy Management in Therapeutic Drug Monitoring of Immunosuppressants
Ursula Wolf
Pharmaceutics (2023) Vol. 15, Iss. 9, pp. 2300-2300
Open Access | Times Cited: 3
Importance of Pharmacogenetics and Drug–Drug Interactions in a Kidney Transplanted Patient
Julia Concha, Estela Sangüesa, Ana Sáez-Benito, et al.
Life (2023) Vol. 13, Iss. 8, pp. 1627-1627
Open Access | Times Cited: 2
The impact of CYP3A4 and CYP3A5 genetic variations on tacrolimus treatment of living‐donor Egyptian kidney transplanted patients
Hanaa Wanas, Mai Hamed Kamel, Emad Adel William, et al.
Journal of Clinical Laboratory Analysis (2023) Vol. 37, Iss. 19-20
Open Access | Times Cited: 2
Pattern of CYP3A5 and MDR-1 single nucleotide polymorphism and its impact on Tacrolimus levels and clinical outcomes in living renal allograft recipient
Sukhwinder Singh Sangha, Sushma Yadav, Raj Kanwar Yadav, et al.
RPS Pharmacy and Pharmacology Reports (2024) Vol. 3, Iss. 2
Open Access
Impact of IL-6 and IL-10 genotypes on tacrolimus dose requirements in kidney transplant recipients: Monte Carlo analysis
Nikola Stefanović, Katarina Danković, Tatjana Cvetković, et al.
Pharmacogenomics (2024) Vol. 25, Iss. 7, pp. 315-327
Closed Access
CYP3A4*1B but Not CYP3A5*3 as Determinant of Long-Term Tacrolimus Dose Requirements in Spanish Solid Organ Transplant Patients
Julia Concha, Estela Sangüesa, María Pilar Ribate, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11327-11327
Open Access
Cyclosporine's immunosuppressive effects, entwined toxicity, and clinical modulations of an organ transplant drug
Razan Alqadi, Amal Alqumia, Ibrahim S. Alhomoud, et al.
Transplant Immunology (2024), pp. 102147-102147
Closed Access
Impact of tacrolimus intra-patient variability in adverse outcomes after organ transplantation
Maria Clara Morais, Maria Eduarda Soares, Gabriela Costa, et al.
World Journal of Transplantation (2023) Vol. 13, Iss. 5, pp. 254-263
Open Access | Times Cited: 1
Bioequivalence evaluation and blood concentration estimation of generic and branded tacrolimus in healthy subjects under fasting: A randomized, four-periods, two-sequences, complete repeated, crossover study
Yulin Niu, Gongbin Lan, Jina Wang, et al.
Transplant Immunology (2023) Vol. 81, pp. 101933-101933
Closed Access | Times Cited: 1
Retrospective pharmacogenetic study in a cohort of pediatric tuberous sclerosis complex patients using everolimus
Julia Concha, Estela Sangüesa, José Luis Peña Segura, et al.
Pharmacogenomics (2023) Vol. 24, Iss. 15, pp. 797-808
Closed Access | Times Cited: 1
Exploring Drug-Drug Interactions: A Network Analysis and Visualization Approach
İlhan Uysal, Utku Köse
Journal of Materials and Mechatronics A (2023) Vol. 4, Iss. 1, pp. 257-270
Open Access
Page 1 - Next Page

Scroll to top